The Pharma Partners (“TPP”) Announces Strategic Alliance Agreement With Brooks, Houghton & Company, Inc. (“BHC”)
May 27, 2015 – New York, NY – The Pharma Partners (“TPP”) today announced that it has entered into an alliance agreement with Brooks, Houghton & Company, Inc. (“BHC”) aimed at connecting and advising healthcare and life sciences companies in the United States and China.
Brooks, Houghton, a New York-based merchant bank established over 25 years ago, has significant experience undertaking investment banking transactions in the healthcare and pharmaceutical industries while maintaining a distinct reputation for quality service. BHC will work in conjunction with TPP to both facilitate and advise on cross-border strategic and financing opportunities between US-based healthcare and life sciences companies and Chinese healthcare institutions.
Gerald Houghton, President of Brooks, Houghton, stated, “Brooks, Houghton & Company, Inc. is very pleased to enter into an alliance with TPP that will permit both firms to provide enhanced services to their respective clients. The alliance will provide a wealth of information to companies in the United States and China and will offer expertise and experience that can be accessed in either country with both firms working in close cooperation with each other.”
Tony Chu, Co-Founder and Managing Partner of TPP, further explained, “TPP is excited to announce our relationship with Brooks, Houghton’s team of knowledgeable and experienced banking professionals. Brooks, Houghton has established itself as a leader in assisting innovative companies in finding the financing needed to achieve great things in the areas of healthcare and science.” TPP and BHC have chosen to collaborate with the purpose of making this alliance a go-to solution for US companies contemplating international opportunities in China. The union of BHC’s targeted solutions-oriented approach to clients’ needs and TPP’s broad network and familiarity with the Chinese healthcare market has been at the foundation of the alliance.
TPP Co-Founder and Managing Partner Asa Cox concluded, “BHC’s expertise has served the healthcare community for over 25 years, and we believe that their mission of gaining access to the capital markets aligns with our goal of bridging the gap between novel American companies and successful Chinese healthcare institutions. We look forward to working together and helping innovative companies find the right strategic partners and investors in China.”
About The Pharma Partners: The Pharma Partners (“TPP”) is an advisory firm specializing in connecting innovative North American and European healthcare and life sciences companies with Chinese investment, manufacturing, and distribution groups.
About Brooks, Houghton & Company, Inc.: Brooks, Houghton & Company, Inc. (“BHC”) is a merchant banking firm located in New York that focuses on debt and equity financing, strategic advisory and M&A and direct investing utilizing dedicated investment funds. The firm’s broker-dealer, Brooks, Houghton Securities, Inc., is a FINRA and SIPC member.